I

Integrum AB
STO:INTEG B

Watchlist Manager
Integrum AB
STO:INTEG B
Watchlist
Price: 10.2 SEK -1.92% Market Closed
Market Cap: kr265.5m

Relative Value

The Relative Value of one INTEG B stock under the Base Case scenario is hidden SEK. Compared to the current market price of 10.2 SEK, Integrum AB is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INTEG B Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

INTEG B Competitors Multiples
Integrum AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Integrum AB
STO:INTEG B
265.5m SEK 2.7 -8.9 -5.8 -5.8
US
Abbott Laboratories
NYSE:ABT
190.1B USD 4.3 29.1 16.5 22.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.4B USD 18 63.4 48.5 58.6
US
Stryker Corp
NYSE:SYK
140.5B USD 5.8 47.9 23.3 28.2
US
Boston Scientific Corp
NYSE:BSX
139.4B USD 7.2 49.9 29.2 39.8
IE
Medtronic PLC
NYSE:MDT
131.6B USD 3.8 27.6 15.5 22.4
US
Becton Dickinson and Co
NYSE:BDX
58.1B USD 2.7 34.7 12.7 21.7
DE
Siemens Healthineers AG
XETRA:SHL
47.2B EUR 2 22 12.6 17.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.1B USD 13 52.6 37.8 41.8
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD 8.1 34.7 24.7 27.1
US
Resmed Inc
NYSE:RMD
37.1B USD 7.1 25.9 18.6 20.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
I
Integrum AB
STO:INTEG B
Average EV/EBITDA: 23.9
Negative Multiple: -5.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.5
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
48.5
24%
2
US
Stryker Corp
NYSE:SYK
23.3
13%
1.8
US
Boston Scientific Corp
NYSE:BSX
29.2
22%
1.3
IE
Medtronic PLC
NYSE:MDT
15.5
8%
1.9
US
Becton Dickinson and Co
NYSE:BDX
12.7
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.6
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.8
14%
2.7
US
Edwards Lifesciences Corp
NYSE:EW
24.7
13%
1.9
US
Resmed Inc
NYSE:RMD
18.6
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
I
Integrum AB
STO:INTEG B
Average EV/EBIT: 30
Negative Multiple: -5.8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.5
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.6
25%
2.3
US
Stryker Corp
NYSE:SYK
28.2
16%
1.8
US
Boston Scientific Corp
NYSE:BSX
39.8
32%
1.2
IE
Medtronic PLC
NYSE:MDT
22.4
17%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.7
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.7
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.8
15%
2.8
US
Edwards Lifesciences Corp
NYSE:EW
27.1
14%
1.9
US
Resmed Inc
NYSE:RMD
20.6
12%
1.7